Key regions: Japan, India, Italy, Brazil, South Korea
The Anti-Hypertensive Drugs market in Angola has been steadily growing over the past few years, with an increasing demand for medications to treat high blood pressure.
Customer preferences: Angolan customers have been showing a preference for generic drugs over branded ones due to their affordability. This trend is not unique to Angola, as generic drugs have been gaining popularity worldwide due to their lower prices. Additionally, customers in Angola have been showing a preference for combination drugs that contain multiple active ingredients, as they are more effective in treating high blood pressure.
Trends in the market: One of the major trends in the Anti-Hypertensive Drugs market in Angola is the increasing availability of medications. This can be attributed to the efforts of the Angolan government to improve the healthcare system and make medications more accessible to the population. Another trend is the increasing use of technology in the distribution of medications, with the rise of e-pharmacies and online ordering systems.
Local special circumstances: One of the unique circumstances in Angola is the prevalence of traditional medicine and herbal remedies. While this may not directly impact the Anti-Hypertensive Drugs market, it does highlight the importance of educating the population on the benefits of modern medicine and the potential dangers of relying solely on traditional remedies.
Underlying macroeconomic factors: The Angolan economy has been experiencing a period of growth, which has led to an increase in disposable income and a growing middle class. This has resulted in an increased demand for healthcare services, including the Anti-Hypertensive Drugs market. Additionally, the government has been investing in the healthcare sector, which has led to improvements in the healthcare infrastructure and an increase in the availability of medications. However, the market is still facing challenges such as a lack of healthcare professionals and inadequate healthcare facilities in rural areas.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
